| Revenue growth | 17% Y-o-Y for FY26. |
|---|---|
| Margins | EBITDA margin stable at 31%; PAT margin improved to 23%. |
| Demand visibility | Strong in Nutrition; 700+ worldwide customers. |
| Management confidence | High, focused on 'Rising Global Star' status. |
Growth
FY26 Revenue grew 17% to ₹7,458 mn; PAT grew 30% to ₹1,736 mn; EBITDA margin at 31%.
Outlook
Focus on Bio-Catalysis for APIs, expanding Probiotics in Human Nutrition, and potential inorganic expansion in new technologies.
Risks
Potential regulatory hurdles for food enzyme dossiers and geographical concentration risk in India and Americas.
Earnings Call filed with NSE, NSE: ADVENZYMES. Summary written with AI assistance from the document.
Advanced Enzyme Technologies Ltd: key numbers
- Share price
- ₹291.15
- Market cap
- ₹3,260 Cr
- Revenue (annual)
- ₹745.8 Cr
- Net profit (annual)
- ₹168.7 Cr
- P/E (TTM)
- 19.6×Sector 50.4×
- Promoter holding
- 43.24%-0.02% QoQ
- FII holding
- 26.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advanced Enzyme Technologies Ltd
All →Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies Ltd bought back 50,000 equity shares on September 25, 2026. This transaction was executed at an average price of ₹295.80 per share.
- Value
- ₹1.48 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 64,668 shares on September 24, 2026, at an average price of ₹298.0272 per share.
- Value
- ₹1.93 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 63,616 shares at an average price of ₹297.47. The total value of today's buyback transaction is ₹1.89 Crore.
- Value
- ₹1.89 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies Ltd repurchased 1,136 equity shares on September 22, 2026, at an average price of ₹295.90. This daily filing is for compliance.
- Value
- ₹0.03 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 50,000 equity shares on September 21, 2026, at an average price of ₹289.49 per share.
- Value
- ₹1.45 Cr
Advanced Enzyme Technologies Promoter Reclassification
Advanced Enzyme Technologies received requests from four promoter group members to reclassify as 'Public' shareholders. These requests are pending board consideration.